BU to Lead $13.6M DOD Lung Cancer Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Department of Defense has awarded Boston University Medical School a $13.6 million grant to lead a multi-site study to discover molecular biomarkers that can be used for the early detection of lung cancer.

The five-year study will seek to identify markers that could help physicians decide which patients require biopsies after having CT scans and could predict which smokers who had no abnormalities in their CT scans will be most likely to get lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.